Cumberland Pharmaceuticals
CPIX
CPIX
25 hedge funds and large institutions have $3.91M invested in Cumberland Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 0 closing their positions.
Holders
25
Holders Change
+4
Holders Change %
+19.05%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
6
Reduced
7
Closed
–
Calls
$77K
Puts
$10K
Net Calls
+$67K
Net Calls Change
-$7K
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$40.4K |
| 2 |
P
2
&Partners
Nashville,
Tennessee
|
$19.7K |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$671K |
| 4 |
CAM
4
Cresset Asset Management
Chicago,
Illinois
|
$21.5K |
| 5 |
TRCT
5
Tower Research Capital (TRC)
New York
|
$10.1K |
Top Sellers
| 1 |
1
Dimensional Fund Advisors
Austin,
Texas
|
$637K |
| 2 |
2
Renaissance Technologies
New York
|
$985K |
| 3 |
3
Citadel Advisors
Miami,
Florida
|
$6.15K |
| 4 |
4
Northern Trust
Chicago,
Illinois
|
$32.6K |
| 5 |
5
Two Sigma Advisers
New York
|
$41.9K |
